COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN BULGARIA

Euromonitor International

February 2019

LIST OF CONTENTS AND TABLES

Headlines

Prospects

Paediatric Remedies on the Rise

Combination Products Struggle Despite Cold and Flu Season

Dynamic Nasal Sprays

Competitive Landscape

Teva Pharmaceuticals Expands Further in Category

Herbal/traditional Players Benefit From Premiumisation Trends

Category Data

Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2013-2018

Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2013-2018

Table 3 Sales of Decongestants by Category: Value 2013-2018

Table 4 Sales of Decongestants by Category: % Value Growth 2013-2018

Table 5 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2014-2018

Table 6 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2015-2018

Table 7 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2018-2023

Table 8 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2018-2023

Executive Summary

Sustainable Growth of Consumer Health

Value and Affordability Shape Demand for Consumer Health

Wholesalers and Distributors Offer Additional Services

Consumer-centricity Powered by Digitalisation

Modernisation Efforts in Bulgaria Promise Stable Growth for Consumer Health

Market Indicators

Table 9 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018

Table 10 Life Expectancy at Birth 2013-2018

Market Data

Table 11 Sales of Consumer Health by Category: Value 2013-2018

Table 12 Sales of Consumer Health by Category: % Value Growth 2013-2018

Table 13 NBO Company Shares of Consumer Health: % Value 2014-2018

Table 14 LBN Brand Shares of Consumer Health: % Value 2015-2018

Table 15 Distribution of Consumer Health by Format: % Value 2013-2018

Table 16 Distribution of Consumer Health by Format and Category: % Value 2018

Table 17 Forecast Sales of Consumer Health by Category: Value 2018-2023

Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023

Appendix

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and Preventive Medicine

Switches

Sources

Summary 1 Research Sources

Paediatric remedies outperformed the overall category driven by growing exposure to viruses in urban areas and a prolonged cold and flu outbreak period. Product variety increased, supported by marketing and promotional activity by players, resulting in increasing consumer awareness of paediatric products. The expanded choice made consumers more deliberate in their purchases and preference for value and affordability. Even though Bulgaria has one of the worst demographic trends associated with lo...

Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies in Bulgaria report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.

Product coverage: Antihistamines/Allergy Remedies (Systemic), Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Paediatric Cough, Cold and Allergy Remedies, Pharyngeal Preparations.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.